ANP32E drives vulnerabiliy to ATR inhibitors in Triple Negative Breast Cancer by accumulation of R-loops
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 150 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 150 samples: 126 distinct titles, 9 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- ANP32E drives vulnerability to ATR inhibitors by inducing R-loops-dependent transcription replication conflicts in triple negative breast cancerNature communications · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE250562_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1054532 and SRA study SRP478897. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 150 sample titles: 126 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7981432 tIMEC cells, rep1, pH2A.X
- GSM7981433 tIMEC cells, rep1, ANP32E, Sigma
- GSM7981434 tIMEC cells, rep1, ANP32E, Abcam
- GSM7981435 tIMEC cells, rep1, ANP32E, LSBio
- GSM7981436 tIMEC cells, rep1, p400
- GSM7981437 tIMEC cells, rep1, TOP2A
- GSM7981438 tIMEC cells, rep1, TOP2B
- GSM7981439 tIMEC cells, rep1, Rloop
- GSM7981440 tIMEC cells, rep1, pRPA32(S33)
- GSM7981441 tIMEC cells, rep1, cMYC
- GSM7981442 tIMEC cells, rep1, pS5RNApolII
- GSM7981443 tIMEC cells, rep1, pS2RNApolII, ActiveMotif
- GSM7981444 tIMEC cells, rep1, pS2RNApolII, Abcam
- GSM7981445 tIMEC cells, rep1, acH2A.Z
- GSM7981446 tIMEC cells, rep1, H2A.Z, Abcam
- GSM7981447 tIMEC cells, rep1, H2A.Z, ActiveMotif
- GSM7981448 tIMEC cells, rep1, Rabbit IgG
- GSM7981449 tIMEC cells, ANP32E overexpression, rep1, pH2A.X
- GSM7981450 tIMEC cells, ANP32E overexpression, rep1, ANP32E, Sigma
- GSM7981451 tIMEC cells, ANP32E overexpression, rep1, ANP32E, Abcam
- GSM7981452 tIMEC cells, ANP32E overexpression, rep1, ANP32E, LSBio
- GSM7981453 tIMEC cells, ANP32E overexpression, rep1, p400
- GSM7981454 tIMEC cells, ANP32E overexpression, rep1, TOP2A
- GSM7981455 tIMEC cells, ANP32E overexpression, rep1, TOP2B
- GSM7981456 tIMEC cells, ANP32E overexpression, rep1, Rloop
- GSM7981457 tIMEC cells, ANP32E overexpression, rep1, pRPA32(S33)
- GSM7981458 tIMEC cells, ANP32E overexpression, rep1, cMYC
- GSM7981459 tIMEC cells, ANP32E overexpression, rep1, pS5RNApolII
- GSM7981460 tIMEC cells, ANP32E overexpression, rep1, pS2RNApolII, ActiveMotif
- GSM7981461 tIMEC cells, ANP32E overexpression, rep1, pS2RNApolII, Abcam
- GSM7981462 tIMEC cells, ANP32E overexpression, rep1, acH2A.Z
- GSM7981463 tIMEC cells, ANP32E overexpression, rep1, H2A.Z, Abcam
- GSM7981464 tIMEC cells, ANP32E overexpression, rep1, H2A.Z, ActiveMotif
- GSM7981465 tIMEC cells, ANP32E overexpression, rep1, Rabbit IgG
- GSM7981466 tIMEC cells, ANP32E and RNaseH1 overexpression, rep1, pH2A.X
- GSM7981467 tIMEC cells, ANP32E and RNaseH1 overexpression, rep1, ANP32E, Sigma
- GSM7981468 tIMEC cells, ANP32E and RNaseH1 overexpression, rep1, ANP32E, Abcam
- GSM7981469 tIMEC cells, ANP32E and RNaseH1 overexpression, rep1, ANP32E, LSBio
- GSM7981470 tIMEC cells, ANP32E and RNaseH1 overexpression, rep1, p400
- GSM7981471 tIMEC cells, ANP32E and RNaseH1 overexpression, rep1, TOP2A
+ 110 more — browse all 150 samples with per-sample file links →
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing · shares negative
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing
- GSE250561 ANP32E drives vulnerabiliy to ATR inhibitors in Triple Negative Breast Cancer by accumulation of R-loops [RNA-Seq] 12 samples shares anp32e, atr, vulnerabiliy, accumulation, inhibitors, negative, r-loops, drives
- GSE281556 Lysosomal sequestration of PARP inhibitors drives heterogeneous accumulation in ovarian cancer to increase efficacy 204 samples shares accumulation, inhibitors, drives
- GSE281517 Lysosomal sequestration of PARP inhibitors drives heterogeneous accumulation in ovarian cancer to increase efficacy [RNA-seq] 72 samples shares accumulation, inhibitors, drives
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.